The Afternoon Update with Lynlee Foo
About
Stay in the know with programs such as Viewpoint and Industry Insights in property, cryptocurrency, aviation, and shipping. We delve into the latest news, current events, and market updates to provide you with valuable insights into making informed financial decisions.
JAN 21, 2022
21/01/22 - Market View Wrap, 21 JanOn Market View, Claressa Monteiro is joined by Geoff Howie, Market Strategist at the SGX as they review the week's market movements - namely SPACs Vertex and Pegasus kicked off their trading on the SGX, factors on why the STI index is nearing 3,300, but not quite yet, commodities performance on the SGX plus a chock-a-block of reports coming out next week, including REITs.
|
|
|
19:22
|
JAN 20, 2022
20/01/22 - Market View, Australian Economy Outlook 2022On Market View, Claressa Monteiro is joined by Kyle Rodda, Analyst at IG, as they unpack the numbers and trends for the Australian economy in 2022 , with focus on ASX, property prices, trade spat with China, global supply chain disruptions as well as the upcoming CPI to be released next week.
|
|
|
16:13
|
JAN 20, 2022
20/01/22 - Chasing Cars : Hyundai TucsonOn Chasing Cars, Claressa Monteiro is joined by Julian Kho, Editor, SgCarMart, as they continue their review of the car of the week : this week, it’s the Hyundai Tucson, SgCarMart’s Most Improved winner.
|
|
|
19:42
|
JAN 19, 2022
19/01/22 - Soul of Business:On the Soul of Business, Claressa Monteiro speaks to Dr Jennifer Bourland, Head of Innovation Domain Cell & Tissue Systems, Evonik and Dr. Massimo Alberti, CEO and Founder, Revivo, on their partnership to develop organ-on-a-chip technology that will revolutionise chemical testing and drug development.
|
|
|
15:26
|
JAN 19, 2022
19/01/22 - Health Suites: Treating Covid-19On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
|
|
|
12:45
|
JAN 19, 2022
19/01/22 - Market View, SPACS on SGX, 19 JanThe buzz in 2022 is on Temasek’s Vertex Venture Holdings and Tikehau Capital SCA-backed Pegasus with both set to kick a first wave of SPAC listing on the Singapore Stock Exchange this week and next week. On Market View, Claressa Monteiro is joined by Emelia Tan, Research Analyst with the SGX as they deep dive into what is a SPAC company? Are there risks involved and if there are, are there any safeguards for investors?
|
|
|
15:08
|
JAN 18, 2022
18/01/22 - Health Suites: Lonely fruit flies aren’t so different from usOn Health Suites, Claressa Monteiro speaks to Professor Michael Young, 2017 Nobel Prize recipient for Physiology or Medicine. She learns more about his current research of fruit flies and the potential correlation to pathological consequences in humans.
|
|
|
17:44
|
JAN 18, 2022
18/01/22 - Health Suites: The Science Behind MedicineOn Health Suites, Claressa Monteirospeaks to Dr Robert Langer, Co-Founder Moderna Inc, to find out more about the man and the science that drives him.
|
|
|
12:57
|
JAN 18, 2022
18/01/22 - Market View: China Market Outlook in 2022, 18 JanOn Market View, Claressa Monteiro picked the brains of China market expert, Jack Kouzi, Director of VFS Group as they talked about China's newly released GDP growth, its embattled property sector, tech stocks under regulatory crackdowns as well as investors' sentiment and market impact from the ongoing virus outbreaks and China's zero-Covid policy.
|
|
|
19:32
|
JAN 17, 2022
17/01/22 - Health Suites: Understanding LupusOn Health Suites, there are between 4,000 to 5,000 patients with lupus in Singapore alone. But what is lupus? Who does it affect and how is it treated?Claressa Monteiro finds out more in her conversation with Dr Chuah Tyng Yu, Associate Consultant, General Medicine at the Sengkang General Hospital.
|
|
|
12:58
|